Central nervous system relapse of primary cutaneous anaplastic large cell lymphoma: A case report

Central nervous system relapse of primary cutaneous anaplastic large cell lymphoma: A case report

Abstract Primary cutaneous anaplastic large cell lymphoma (PC‐ALCL) has a high relapse rate. However, it typically remains confined to the skin and has a favorable long‐term prognosis. We describe a case of PC‐ALCL that experienced a relapse in the central nervous system (CNS). The patient presented...

Full description

Saved in:

Bibliographic Details
Main Authors:	Satoshi Mitsuyuki, Sayaka Okazaki, Satoru Mukai, Ai Matsuura, Yumiko Yasuhara, Aya Tanaka, Koichi Oshima, Kazuo Hatanaka
Format:	Article
Language:	English
Published:	Wiley 2025-04-01
Series:	eJHaem
Subjects:	case report peripheral T‐cell lymphoma primary cutaneous anaplastic large cell lymphoma secondary CNS lymphoma
Online Access:	https://doi.org/10.1002/jha2.1082
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Primary Breast Anaplastic Large-Cell Lymphoma
by: Min-Hong Wang, et al.
Published: (2023-10-01)

A Rare Case of Anaplastic Lymphoma Kinase-negative Anaplastic Large Cell Lymphoma Presenting as Right Heart Failure
by: U. Harikishore, et al.
Published: (2025-01-01)

Involvement of the central nervous system in relapsed T-cell lymphoma: insights from four case studies
by: Radu Chiriac, et al.
Published: (2025-01-01)

Breast implant-associated anaplastic large-cell lymphoma: a systematic literature review
by: Daniel Sundfeld Spiga Real, et al.
Published: (2019-12-01)

A case of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T‐cell lymphoma
by: Tomomichi Shimizu, et al.
Published: (2025-03-01)

An Isolated Cutaneous Relapse in a Known Case of Systemic ALK-Positive Anaplastic Large Cell Lymphoma: A Rare Case Report with Review of Literature
by: Monisha Shetty, et al.

An Ulcerated Nodule on the Toe in an Elderly Patient: A Quiz
by: Ziqi Liu, et al.
Published: (2025-04-01)

Assessment of the Tolerability and Optimal Dosing of the Combination of Brentuximab Vedotin and Lenalidomide in Patients With Relapsed or Refractory T‐cell Lymphoma: Results of a Single‐centre Phase 1 Dose‐escalation Study
by: Carrie van der Weyden, et al.
Published: (2025-06-01)

ALK-negative anaplastic large-cell lymphoma diagnosed on liver biopsy in a child presenting with nonresolving pyrexia
by: Aanchal Kakkar, et al.
Published: (2019-01-01)

Recurrent primary pulmonary anaplastic B-cell lymphoma in a 35-year-old patient treated with radical resection: A case report.
by: George Bashour, et al.
Published: (2025-03-01)

T-CELL LYMPHOMA DIAGNOSIS AND TREATMENT IN KOSOVO, A CROSS SECTIONAL STUDY
by: Adriatik Berisha
Published: (2025-07-01)

Differentiated, immunobased approach of anaplastic large cell lymphoma treatment in children and adolescents: literature review and protocol ALCL-NII DOG-2003 results
by: A. S. Volkova, et al.
Published: (2023-05-01)

An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement
by: Andrew J. Sunderland, et al.
Published: (2020-01-01)

Primary bone ALK-positive anaplastic large cell lymphoma presented as a giant extraskeletal mass with coagulation necrosis
by: Shuji Nagata, et al.
Published: (2025-09-01)

Modern Aspects of Diagnosis and Treatment of Anaplastic Large Cell Lymphoma in Children (Literature Review)
by: AS Levashov, et al.
Published: (2016-04-01)

Successful treatment of post chemotherapy esophageal cicatricial atresia in a pediatric patient with anaplastic large cell lymphoma through minimally invasive esophagectomy: a case report
by: Yuto Hozaka, et al.
Published: (2021-02-01)

Treatment of central nervous system lymphoma — literature review and own experiences
by: S. V. Minenko, et al.
Published: (2014-07-01)

PRIMARY PALATAL ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: RARITY TREATED SUCCESSFULLY WITH BRENTUXIMAB VEDOTIN
by: Müjgan Çözeli, et al.
Published: (2024-12-01)

MOLECULAR BIOLOGICAL CHARACTERISTICS OF ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA
by: E. V. Chernyshova, et al.
Published: (2017-01-01)

Brentuximab vedotin in children and adolescents with Hodgkin’s lymphoma and anaplastic large cell lymphoma – literature review and own experience
by: N. V. Myakova, et al.
Published: (2016-03-01)

Implant-associated anaplastic large T-cell lymphoma (BIA-ALCL): case report
by: Antônio de Pádua Peppe, et al.
Published: (2024-07-01)

Children with lymphoma presenting with hemophagocytic lymphohistiocytosis
by: Tekin Aksu, et al.
Published: (2020-04-01)

First Case Report of Breast Implant Associated-Anaplastic Large Cell Lymphoma from India: Are We Ready?
by: Soumya Khanna, et al.
Published: (2023-04-01)

Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
by: Ruben Fernandez, et al.
Published: (2014-02-01)

Overall and Cause‐Specific Mortality Among Patients With Cutaneous T‐Cell Lymphoma in the United States
by: Lauren Shea, et al.
Published: (2025-04-01)

Anaplastic Large Cell Lymphoma with Generalized Skin Lesion in Childhood: Clinical Case
by: Timur T. Valiev, et al.
Published: (2020-12-01)

Rapidly enlarging primary cutaneous anaplastic large T-cell lymphoma of the eyelid-A case report
by: Vijay Kumar, et al.
Published: (2024-10-01)

Unusual presentation of skin nodule in a child: a case report of primary cutaneous CD4<sup>+</sup> small/medium T-cell lymphoproliferative disorder and literature review
by: Lama Aloraifi, et al.
Published: (2025-05-01)

Unspecified skin peripheral T-cell lymphoma: diagnostic difficulties
by: O. Yu. Olisova, et al.
Published: (2020-10-01)

Real-world experiences with brentuximab vedotion-based regimens in systemic anaplastic large cell lymphoma: a multi-center retrospective study
by: Zhiqiang Zhao, et al.
Published: (2025-01-01)

TET2-mediated 5-hydroxymethylcytosine of TXNIP promotes cell cycle arrest in systemic anaplastic large cell lymphoma
by: Ziqing Yu, et al.
Published: (2025-01-01)

Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma
by: Ahmed Salah, et al.
Published: (2025-05-01)

SYSTEMATIC REVIEW: ANAPLASTIC LARGE CELL LYMPHOMA FOLLOWING BREAST IMPLANT SURGERY
by: Kezia Eveline, et al.
Published: (2023-06-01)

Overcoming Resistance in Relapsed Anaplastic Large-Cell Lymphoma, ALK-Positive (Literature Review and Clinical Experience)
by: YuE Vinogradova, et al.
Published: (2019-03-01)

Corrigendum: Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma
by: Ahmed Salah, et al.
Published: (2025-06-01)

Non-Hodgkin’s Lymphomas in Children: 25-Year Clinical Experience
by: TT Valiev, et al.
Published: (2016-10-01)

Ibrutinib in primary central nervous system diffuse large B-cell lymphoma
by: Justin T Low, et al.
Published: (2020-03-01)

Report of a case of anaplastic large cell lymphoma associated with a breast implant in a Brazilian patient
by: Bernardo Nogueira Batista, et al.
Published: (2017-09-01)

Primary diffuse cutaneous large B-cell lymphoma, anaplastic type
by: S. V. Antonyuk, et al.
Published: (2012-04-01)

Anaplastic meningioma to supraclavicular lymph node with malignant B cell lymphoma: A rare case report
by: Shrinjay Vyas, et al.
Published: (2025-06-01)